Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 3, 2005, Pages 163-167

  Gandhok, Navjeet K ^a   Looney, Stephen ^a   Koochekpour, Shahriar ^a   Sartor, Oliver ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hormone refractory prostate cancer; Prognosis; PSA mRNA; RT PCR; Survival

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN;

AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 19344363332     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.11.009     Document Type: Article

References (13)

1. A. Jemal, T. Murray, A. Samuels Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
2. P. Sabbatini, S.M. Larson, A. Kremer Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer J Clin Oncol 17 1999 948 957
3. J.G. Moreno, C.M. Croce, R. Fischer Detection of hematogenous micrometastasis in patients with prostate cancer Cancer Res 52 1992 6110 6112
4. P.W. Kantoff, S. Halabi, D.A. Farmer Prognostic significance of reverse transcriptase-polymerase chain reaction for prostate-specific antigen in men with hormone refractory prostate cancer J Clin Oncol 19 2001 3025 3028
5. R.A. Ghossein, J. Rosai, H.I. Scher Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma Urology 50 1997 100 105
6. A. Mejean, G. Vona, B. Nalpas Detection of circulating prostate-derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence J Urol 163 2000 2022 2029
7. M.S. Soloway, S. Ishikawa, R. van der Zwaag Prognostic factors in patients with advanced prostate cancer Urology 33 1989 53 56
8. W.K. Kelly, H.I. Scher, M. Mazumdar Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer J Clin Oncol 11 1993 607 615
9. S. Halabi, M.R. Conaway, E.J. Small Serum prostate specific antigen as a predictor of survival in prostate cancer patients treated with second-line hormonal therapy (CALGB 9181) Prostate J 3 2001 18 25
10. S. Halabi, E.J. Small, P.W. Kantoff Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer J Clin Oncol 21 2003 1232 1237
11. L.J. Emrich, R.L. Priore, G.P. Murphy Prognostic factors in patients with advanced stage prostate cancer Cancer Res 45 1985 5173 5179
12. P. Schulz, R. Stucka, H. Feldmann Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence Nucleic Acids Res 16 1988 6226
13. M.G. Oefelein, P.K. Agarwal, M.I. Resnick Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era J Urol 171 2004 1525 1528